• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ACAD

ACAD

ACADIA Pharmaceuticals Inc.

NASDAQHealthcareBiotechnologyUS

USD21.43

+0.54 (+2.58%)

Rating:B+

Company Profile

CEO

Catherine E. Owen Adams

IPO Date

2004-05-27

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$20.87

Prev. Close

$20.89

Day Low

$20.76

Day High

$21.44

52W Low

$19.69

52W High

$28.35

Market Cap

$3.67B

Volume

1.23M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBearish

Articles

10

Avg Positive

4.0%

Avg Negative

48.1%

Avg Neutral

47.9%

News Feed

The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis

Business Wire·7/21/2021·↑ positive

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 21, 2021 - ACAD

Newsfile Corp·6/21/2021·↓ negative

ACAD INVESTOR DEADLINE MONDAY: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now

Newsfile Corp·6/19/2021·↓ negative

DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp·6/18/2021·↓ negative

Final Deadline for Investors to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC

Newsfile Corp·6/18/2021·↓ negative

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp·6/17/2021·↓ negative

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)

Business Wire·6/16/2021·↓ negative

Two Days Left to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC

Business Wire·6/16/2021·↓ negative

FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp·6/16/2021·↓ negative

FRIDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp·6/15/2021·↓ negative